Literature DB >> 20505545

Use of complementary and alternative therapy by women in the first 2 years after diagnosis and treatment of invasive breast cancer.

Susan R Davis1, Marijana Lijovic, Pam Fradkin, Jo Bradbury, Maria La China, Max Schwarz, Robin J Bell.   

Abstract

OBJECTIVE: Our aim was to document patterns of consultation with alternative practitioners, use of complementary and alternative medicine (CAM) commonly used to alleviate menopausal symptoms, and lifestyle changes made by women in the first 2 years after their diagnosis with invasive breast cancer.
METHODS: A total of 1,588 women in the MBF Foundation Health and Wellbeing After Breast Cancer Study completed both the enrollment questionnaire and the first follow-up questionnaire (FQ1), on average, 41 and 92 weeks after diagnosis, respectively. The Menopause Quality of Life Questionnaire and the Psychological General Wellbeing Index were included in the FQ1. Logistic regression analysis was used to examine characteristics associated with consulting a CAM practitioner or using CAMs.
RESULTS: At the time of completion of the FQ1, 16.4% of women had consulted a CAM practitioner and 10.6% reported using at least one CAM commonly used to alleviate menopausal symptoms. Women who consulted a CAM practitioner and women who were using at least one CAM at the time of completion of the FQ1 were, on average, younger and more educated and had a higher Menopause Quality of Life Questionnaire score than did women who did not. Of the women, 33.6% reported having made a dietary change, and the most common lifestyle change was an increase in physical activity, which was reported by 29.0% of women.
CONCLUSIONS: The frequency of use of CAMs in common usage for menopausal symptoms by women with breast cancer was lower than anticipated, increased with time from diagnosis, and is associated with more severe menopausal symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20505545     DOI: 10.1097/gme.0b013e3181d991dd

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  6 in total

1.  Older adults' self-management of daily symptoms: complementary therapies, self-care, and medical care.

Authors:  Thomas A Arcury; Joseph G Grzywacz; Rebecca H Neiberg; Wei Lang; Ha Nguyen; Kathryn Altizer; Eleanor P Stoller; Ronny A Bell; Sara A Quandt
Journal:  J Aging Health       Date:  2011-12-20

2.  Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia.

Authors:  Robin J Bell; Marijana Lijovic; Pamela Fradkin; Max Schwarz; Susan R Davis
Journal:  Support Care Cancer       Date:  2011-04-09       Impact factor: 3.603

3.  Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer.

Authors:  Kavita D Chandwani; Charles E Heckler; Supriya G Mohile; Karen M Mustian; Michelle Janelsins; Luke J Peppone; Peter Bushunow; Patrick J Flynn; Gary R Morrow
Journal:  Explore (NY)       Date:  2014-04-18       Impact factor: 1.775

4.  Effects of Chinese medicinal herbs on expression of brain-derived Neurotrophic factor (BDNF) and its interaction with human breast cancer MDA-MB-231 cells and endothelial HUVECs.

Authors:  Jen-Hwey Chiu; Fang-Pey Chen; Yi-Fang Tsai; Man-Ting Lin; Ling-Ming Tseng; Yi-Ming Shyr
Journal:  BMC Complement Altern Med       Date:  2017-08-12       Impact factor: 3.659

5.  Latent class analysis suggests four distinct classes of complementary medicine users among women with breast cancer.

Authors:  Garrett Strizich; Marilie D Gammon; Judith S Jacobson; Melanie Wall; Page Abrahamson; Patrick T Bradshaw; Mary Beth Terry; Susan Teitelbaum; Alfred I Neugut; Heather Greenlee
Journal:  BMC Complement Altern Med       Date:  2015-11-19       Impact factor: 3.659

6.  Building an Integrative Outpatient Care Program for Breast Cancer Patients in Taiwan.

Authors:  Yi-Hsien Lin; Jing-Huei Shiu; Fang-Pey Chen; Jen-Hwey Chiu
Journal:  Integr Cancer Ther       Date:  2015-10-09       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.